Trial site
The Second Hospital of Dalian Medical University
- 34running trials
- 14closed trials
The trials here
What the 49 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer6 trials
- Lung cancer5 trials
- Ovarian cancer5 trials
- Mantle cell lymphoma4 trials
- Cervical cancer3 trials
- Gastric and oesophageal cancer3 trials
- Head and neck cancer3 trials
- Triple-negative breast cancer3 trials
- Ulcerative colitis3 trials
- Chronic lymphocytic leukaemia2 trials
- Diffuse large B-cell lymphoma2 trials
- Endometrial cancer2 trials
- and 15 more
- Phase
- Phase 323 trials
- Phase 211 trials
- Phase 1/23 trials
- Phase 43 trials
- Phase 2/32 trials
- Phase 11 trial
- Status
- Recruiting14 trials
- Completed12 trials
- Active, not recruiting11 trials
- Not yet recruiting8 trials
- Enrolling by invitation1 trial
- Suspended1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.3 trials
- Biotheus Inc.2 trials
- Hansoh BioMedical R&D Company2 trials
- InnoCare Pharma Inc.2 trials
- and 35 more
Running trials
Enrolling by invitation
Recruiting
Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer
Recruiting
Recruiting
Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
Recruiting
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules
Active, not recruiting
Recruiting
A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL
Recruiting
Recruiting
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Recruiting
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Head and neck cancer2 recruiting
- Lung cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Cervical cancer1 recruiting
- Follicular lymphoma1 recruiting
- Graves' disease1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Liver and biliary tract cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Stroke1 recruiting
- Triple-negative breast cancer1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Recruiting
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
Completed
Terminated
TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Completed
Completed
Completed
Completed
Completed
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Completed
Completed
A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026